Abbott Laboratories Gross Margin 2010-2024 | ABT

Current and historical gross margin for Abbott Laboratories (ABT) over the last 10 years. The current gross profit margin for Abbott Laboratories as of September 30, 2024 is %.
Abbott Laboratories Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $41.22B $22.90B 55.55%
2024-06-30 $40.73B $22.50B 55.24%
2024-03-31 $40.33B $22.22B 55.10%
2023-12-31 $40.11B $22.13B 55.18%
2023-09-30 $39.96B $21.95B 54.92%
2023-06-30 $40.23B $22.19B 55.16%
2023-03-31 $41.51B $23.02B 55.46%
2022-12-31 $43.65B $24.51B 56.15%
2022-09-30 $45.03B $25.72B 57.11%
2022-06-30 $45.55B $26.44B 58.05%
2022-03-31 $44.51B $25.39B 57.04%
2021-12-31 $43.08B $24.54B 56.97%
2021-09-30 $42.31B $24.04B 56.83%
2021-06-30 $40.23B $22.43B 55.74%
2021-03-31 $37.34B $21.22B 56.82%
2020-12-31 $34.61B $19.61B 56.65%
2020-09-30 $32.22B $18.28B 56.72%
2020-06-30 $31.44B $18.11B 57.59%
2020-03-31 $32.10B $18.74B 58.40%
2019-12-31 $31.90B $18.67B 58.53%
2019-09-30 $31.36B $18.37B 58.58%
2019-06-30 $30.94B $18.14B 58.64%
2019-03-31 $30.72B $17.92B 58.34%
2018-12-31 $30.58B $17.87B 58.45%
2018-09-30 $30.40B $17.61B 57.91%
2018-06-30 $29.58B $17.07B 57.71%
2018-03-31 $28.45B $16.03B 56.36%
2017-12-31 $27.39B $14.98B 54.70%
2017-09-30 $25.13B $13.63B 54.21%
2017-06-30 $23.61B $12.69B 53.75%
2017-03-31 $22.30B $12.29B 55.09%
2016-12-31 $20.85B $11.76B 56.39%
2016-09-30 $20.71B $11.79B 56.93%
2016-06-30 $20.56B $11.68B 56.83%
2016-03-31 $20.39B $11.59B 56.82%
2015-12-31 $20.41B $11.66B 57.13%
2015-09-30 $20.57B $11.70B 56.85%
2015-06-30 $20.50B $11.55B 56.32%
2015-03-31 $20.39B $11.36B 55.74%
2014-12-31 $20.25B $11.03B 54.47%
2014-09-30 $18.90B $10.06B 53.21%
2014-06-30 $18.65B $9.87B 52.92%
2014-03-31 $19.03B $10.00B 52.53%
2013-12-31 $19.66B $10.46B 53.23%
2013-09-30 $18.84B $9.92B 52.68%
2013-06-30 $19.28B $10.13B 52.55%
2013-03-31 $19.14B $10.17B 53.13%
2012-12-31 $19.05B $10.15B 53.29%
2012-09-30 $26.24B $15.18B 57.86%
2012-06-30 $30.79B $18.25B 59.27%
2012-03-31 $35.09B $21.05B 59.99%
2011-12-31 $38.85B $23.31B 60.00%
2011-09-30 $38.44B $22.69B 59.03%
2011-06-30 $37.30B $21.78B 58.40%
2011-03-31 $36.51B $21.32B 58.39%
2010-12-31 $35.17B $20.50B 58.30%
2010-09-30 $33.99B $19.58B 57.62%
2010-06-30 $33.08B $19.05B 57.60%
2010-03-31 $31.74B $18.14B 57.13%
2009-12-31 $30.76B $17.56B 57.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $196.826B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $146.166B 32.94
Boston Scientific (BSX) United States $145.408B 41.81
EssilorLuxottica (ESLOY) France $115.383B 0.00
Medtronic (MDT) Ireland $112.944B 16.78
Lonza Group Ag (LZAGY) Switzerland $43.849B 0.00
Haleon (HLN) United Kingdom $41.827B 27.18
GE HealthCare Technologies (GEHC) United States $38.715B 20.08
ResMed (RMD) United States $35.199B 28.92
Terumo (TRUMY) Japan $27.980B 0.00
Koninklijke Philips (PHG) Netherlands $24.250B 18.56
Zimmer Biomet Holdings (ZBH) United States $21.811B 13.89
Insulet (PODD) United States $19.347B 77.04
Baxter (BAX) United States $15.818B 10.29
Smith & Nephew SNATS (SNN) United Kingdom $11.057B 0.00
Bio-Rad Laboratories (BIO) United States $9.586B 32.58
BellRing Brands (BRBR) United States $9.323B 37.51
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.360B 14.78
ICU Medical (ICUI) United States $4.012B 38.20
Prestige Consumer Healthcare (PBH) United States $3.882B 19.31
Haemonetics (HAE) United States $3.691B 18.01
Envista Holdings (NVST) United States $3.413B 25.42
Perrigo (PRGO) Ireland $3.252B 9.57
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.807B 18.07
GN Store Nord (GNNDY) Denmark $2.585B 16.58
Neogen (NEOG) United States $2.508B 28.90
LeMaitre Vascular (LMAT) United States $2.227B 54.13
AtriCure (ATRC) United States $1.876B 0.00
Green Thumb Industries (GTBIF) United States $1.572B 27.52
AdaptHealth (AHCO) United States $1.416B 10.11
InMode (INMD) Israel $1.410B 8.48
BioLife Solutions (BLFS) United States $1.213B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.205B 0.00
Owens & Minor (OMI) United States $1.124B 8.78
Curaleaf Holdings (CURLF) Canada $0.981B 0.00
Phibro Animal Health (PAHC) United States $0.843B 14.87
CeriBell (CBLL) United States $0.754B 0.00
Evolus (EOLS) United States $0.666B 0.00
Capricor Therapeutics (CAPR) United States $0.623B 0.00
VAREX IMAGING (VREX) United States $0.557B 24.58
Omeros (OMER) United States $0.541B 0.00
Surmodics (SRDX) United States $0.527B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.434B 0.00
ZimVie (ZIMV) United States $0.394B 33.23
Valneva SE (VALN) France $0.355B 0.00
Quanterix (QTRX) United States $0.342B 0.00
Cerus (CERS) United States $0.332B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.18
Biote (BTMD) United States $0.306B 6.71
Sanara MedTech (SMTI) United States $0.285B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.25
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.245B 51.20
Canopy Growth (CGC) Canada $0.237B 0.00
Sanuwave Health (SNWV) United States $0.226B 3.18
Aurora Cannabis (ACB) Canada $0.211B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.56
Organigram Holdings (OGI) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.192B 102.30
MacroGenics (MGNX) United States $0.188B 0.00
TerrAscend (TSNDF) Canada $0.168B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.149B 18.77
Veru (VERU) United States $0.143B 0.00
Jin Medical (ZJYL) China $0.143B 0.00
Quipt Home Medical (QIPT) United States $0.130B 0.00
Fonar (FONR) United States $0.096B 10.87
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
INLIF (INLF) $0.078B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.070B 0.00
Rockwell Medical (RMTI) United States $0.069B 35.33
Jushi Holdings (JUSHF) United States $0.063B 0.00
Ayr Wellness (AYRWF) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.11
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00